Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
328.36
+0.89 (0.27%)
At close: Dec 23, 2024, 4:00 PM
327.20
-1.16 (-0.35%)
Pre-market: Dec 24, 2024, 5:57 AM EST
Bio-Rad Laboratories Employees
Bio-Rad Laboratories had 8,030 employees as of December 31, 2023. The number of employees decreased by 170 or -2.07% compared to the previous year.
Employees
8,030
Change (1Y)
-170
Growth (1Y)
-2.07%
Revenue / Employee
$321,321
Profits / Employee
-$96,973
Market Cap
9.19B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8,030 | -170 | -2.07% |
Dec 31, 2022 | 8,200 | 300 | 3.80% |
Dec 31, 2021 | 7,900 | -100 | -1.25% |
Dec 31, 2020 | 8,000 | -120 | -1.48% |
Dec 31, 2019 | 8,120 | -140 | -1.69% |
Dec 31, 2018 | 8,260 | 110 | 1.35% |
Dec 31, 2017 | 8,150 | -100 | -1.21% |
Dec 31, 2016 | 8,250 | 480 | 6.18% |
Dec 31, 2015 | 7,770 | 170 | 2.24% |
Dec 31, 2014 | 7,600 | -150 | -1.94% |
Dec 31, 2013 | 7,750 | 370 | 5.01% |
Dec 31, 2012 | 7,380 | 350 | 4.98% |
Dec 31, 2011 | 7,030 | 150 | 2.18% |
Dec 31, 2010 | 6,880 | 280 | 4.24% |
Dec 31, 2009 | 6,600 | 0 | - |
Dec 31, 2008 | 6,600 | 200 | 3.13% |
Dec 31, 2007 | 6,400 | 1,000 | 18.52% |
Dec 31, 2006 | 5,400 | 200 | 3.85% |
Dec 31, 2005 | 5,200 | 0 | - |
Dec 31, 2004 | 5,200 | 400 | 8.33% |
Dec 31, 2003 | 4,800 | 200 | 4.35% |
Dec 31, 2002 | 4,600 | 300 | 6.98% |
Dec 31, 2001 | 4,300 | 500 | 13.16% |
Dec 31, 2000 | 3,800 | -300 | -7.32% |
Dec 31, 1999 | 4,100 | 1,425 | 53.27% |
Dec 31, 1998 | 2,675 | 25 | 0.94% |
Dec 31, 1997 | 2,650 | 115 | 4.54% |
Dec 31, 1996 | 2,535 | 75 | 3.05% |
Dec 31, 1995 | 2,460 | 130 | 5.58% |
Dec 31, 1994 | 2,330 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Charles River Laboratories International | 21,800 |
Bio-Rad Laboratories | 8,030 |
Qiagen | 5,967 |
Penumbra | 4,200 |
Masimo | 3,800 |
Exelixis | 1,310 |
BIO News
- 4 weeks ago - Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference - Business Wire
- 7 weeks ago - Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference - Business Wire
- 7 weeks ago - Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit - Reuters
- 7 weeks ago - Bio-Rad Reports Third-Quarter 2024 Financial Results - Business Wire
- 2 months ago - Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024 - Business Wire
- 3 months ago - Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 - PRNewsWire
- 4 months ago - Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference - Business Wire